Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Primary Immunogenicity Objective • To describe the immune response, relative to baseline status, following receipt of Bexsero as measured by hSBA performed with a panel of MnB test strains assessed 1 month after the second vaccination with Bexsero vaccine. Primary Safety Objective • To describe local reactions and systemic events following receipt of Bexsero vaccine.
Critère d'inclusion
- Test the safety and immunogenicity of Bexsero used as a vaccine for Neisseria meningitidis